Brello Health Semaglutide Cost: Plans, Fees and Renewal Pricing

Last reviewed: September 13, 2026 Last updated: September 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Brello Health charges $399 upfront for a three-month supply of compounded semaglutide injection (a prepaid rate of $133 per month) and $499 every 11 weeks for compounded tirzepatide injection (a prepaid rate of approximately $197 per month over 12 months). Both prices are all-inclusive—medication, provider visit, and shipping—with no separate membership or service fees. Semaglutide requires a three-month minimum commitment; tirzepatide rebills every 11 weeks and may be canceled anytime. Over a full year, Brello's prepaid structure costs $1,596 for semaglutide and $2,359 for tirzepatide. PlexusDx charges $189 per month for semaglutide and $289 per month for tirzepatide on a month-to-month basis with no upfront commitment, totaling $2,268 and $3,468 annually. Brello offers a lower total cost if you can commit upfront; PlexusDx offers flexible month-to-month billing and a shorter financial commitment.

At-a-glance comparison

All prices captured September 4, 2026 (Brello Health) and July 2026 (PlexusDx). 12-month calculations are ours.

Brello Health pricing structure and renewal mechanics

Brello Health operates on a prepaid model. For compounded semaglutide injection, you pay $399 upfront for a three-month supply. This works out to a prepaid equivalent of $133 per month. Semaglutide requires a three-month minimum commitment; we recommend confirming the exact renewal cadence at checkout, as the evidence shows a minimum term but does not specify whether renewal is automatic or opt-in after the first cycle.

For compounded tirzepatide injection, Brello charges $499 every 11 weeks on a recurring basis. You may cancel anytime. The 11-week cycle is shorter than a calendar quarter: over 52 weeks you will be billed 4.727 times, bringing the effective 12-month cost to approximately $2,359, or a prepaid equivalent of $197 per month (our calculation). The advertised per-month figure of $166.33 assumes exactly three cycles over 33 weeks and does not reflect a full year.

Both prices are all-inclusive. Brello does not charge a separate membership fee, provider visit fee, or shipping fee.

PlexusDx pricing for comparison

PlexusDx offers compounded semaglutide injection at $189 per month and compounded tirzepatide injection at $289 per month, both billed month-to-month with no upfront commitment and no membership fee. The same flat rate applies at every dose. Over 12 months, semaglutide totals $2,268 and tirzepatide totals $3,468.

Normalized 12-month cost comparison

To compare prepaid blocks and month-to-month billing on equal terms, we calculated the total cost of each medication over 12 continuous months.

All figures are our calculation based on verified pricing as of September 4, 2026 (Brello Health) and July 2026 (PlexusDx).

Semaglutide: Brello's $399 three-month block repeats four times in 12 months, totaling $1,596. PlexusDx's $189 month-to-month rate totals $2,268. Brello saves $672 annually if you commit to prepaid blocks.

Tirzepatide: Brello's $499 charge recurs every 11 weeks (4.727 cycles per year), totaling approximately $2,359. PlexusDx's $289 month-to-month rate totals $3,468. Brello saves $1,109 annually.

The tradeoff is liquidity and flexibility. Brello requires $399 or $499 upfront and locks semaglutide into three-month cycles. PlexusDx spreads the cost across smaller monthly payments and allows you to stop or pause without forfeiting prepaid funds.

What's included and what costs extra

Both Brello Health and PlexusDx bundle the provider consultation, prescription, compounded medication, and shipping into the advertised price. Neither program charges a separate membership fee, annual fee, or per-visit consultation fee.

Insurance does not cover compounded GLP-1 medications. Both programs operate on a private-pay basis.

Contract terms, cancellation, and renewal

Brello Health's semaglutide plan requires a three-month minimum commitment. You pay $399 upfront for the first cycle; confirm at checkout whether subsequent cycles renew automatically or require manual reorder. Tirzepatide rebills automatically every 11 weeks and may be canceled anytime before the next billing date.

PlexusDx operates month-to-month with no contract and no minimum term. You may pause or cancel before the next monthly billing cycle.

Medication details: compounded semaglutide and tirzepatide

Both Brello Health and PlexusDx dispense compounded semaglutide and tirzepatide as subcutaneous injections. Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

PlexusDx works with licensed 503A compounding pharmacies.

Doses typically start low and increase over weeks or months under clinical supervision. Both programs follow licensed provider protocols for titration. Neither provider guarantees a specific dose, outcome, or eligibility.

Choose Brello Health if…

• You can afford $399 (semaglutide) or $499 (tirzepatide) upfront and want the lowest 12-month total cost.
• You are comfortable committing to a three-month cycle for semaglutide or an 11-week cycle for tirzepatide.
• You prefer a single all-inclusive price with no membership fees and are willing to prepay for cost savings.

Choose PlexusDx if…

• You want to spread the cost into smaller month-to-month payments with no upfront commitment.
• You value the flexibility to pause or stop without forfeiting prepaid funds.
• You prefer a transparent single rate at every dose with no contract term.

Methodology and freshness

We captured Brello Health pricing from the company's public semaglutide and tirzepatide product pages on September 4, 2026. PlexusDx pricing was verified in July 2026 from live product pages. All 12-month cost calculations, effective monthly rates, and cycle counts are our own arithmetic based on the verified per-cycle or per-month prices. We label all derived figures as "our calculation." Per-month equivalents for prepaid plans are labeled as prepaid equivalents to distinguish them from true month-to-month rates.

We apply the same verification and citation standards to PlexusDx and to competing providers. Where evidence conflicts or is incomplete, we state the conflict and advise confirming at checkout.

Frequently Asked Questions

Does Brello Health charge a membership fee?

No. Brello Health does not charge a separate membership or service fee. The $399 semaglutide and $499 tirzepatide prices are all-inclusive and cover the provider visit, prescription, medication, and shipping.

Can I pay month-to-month with Brello Health?

No. Brello Health requires prepayment in multi-week or multi-month blocks: three months upfront for semaglutide ($399) and every 11 weeks for tirzepatide ($499). PlexusDx offers true month-to-month billing with no upfront commitment.

What is the upfront cost for Brello semaglutide?

The upfront cost is $399 for a three-month supply of compounded semaglutide injection. This works out to a prepaid equivalent of $133 per month. PlexusDx charges $189 per month with an upfront cost of $189.

How does the 11-week tirzepatide cycle work?

Brello Health bills $499 every 11 weeks for tirzepatide, which is shorter than a calendar quarter. Over 52 weeks you are billed approximately 4.727 times, bringing the 12-month total to about $2,359. You may cancel before the next billing cycle.

Are compounded GLP-1 medications FDA-approved?

No. Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Sources

• Brello Health semaglutide pricing and plan structure, captured September 4, 2026 from https://www.brellohealth.com/home1
• Brello Health tirzepatide pricing and renewal terms, captured September 4, 2026 from https://tirzepatidewoo.brellohealth.com/
• PlexusDx semaglutide and tirzepatide pricing, captured July 2026 from https://plexusdx.com/products/semaglutide-injection and https://plexusdx.com/products/tirzepatide-injection
• PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four-star or higher), captured September 9, 2026 from https://www.trustpilot.com/review/plexusdx.com

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.